Misonix.jpg
Misonix Fiscal 2020 Third Quarter Revenue Rises to $17.9 Million
11 mai 2020 16h05 HE | MISONIX, Inc.
FARMINGDALE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix.jpg
MISONIX REPORTS PRELIMINARY FISCAL 2020 THIRD QUARTER REVENUE OF APPROXIMATELY $17.9 MILLION
02 avr. 2020 10h00 HE | MISONIX, Inc.
With Focus on Maintaining Our Objective of Shareholder Value Creation, Company to Prioritize Cash Preservation Through Expense Reduction, Workforce Efficiency and Operational Synergies ...
misonix.jpg
Misonix Reports Record Quarterly Revenue of $19.7 Million for Fiscal 2020 Second Quarter
05 févr. 2020 16h05 HE | MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
microcures logo.jpg
MicroCures Advances Burn Wound Healing Program Under Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR)
28 janv. 2020 08h05 HE | MicroCures, Inc.
$1 Million in Funding from the USAISR Supporting Collaborative Research Project Pilot Animal Study Successfully Completed; Larger Preclinical Study Underway NEW YORK, Jan. 28, 2020 (GLOBE...
microcures logo.jpg
MicroCures Awarded $1.5M SBIR Grant To Support Development of Novel Therapeutic Platform for Accelerated Tissue Repair
07 janv. 2020 08h05 HE | MicroCures, Inc.
NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- MicroCures, a biopharmaceutical company developing novel therapeutics that harness the body’s innate regenerative mechanisms to accelerate tissue repair,...
MilanaPharm logo
MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation
09 mai 2019 10h11 HE | MilanaPharm
TALLASSEE, Ala., May 09, 2019 (GLOBE NEWSWIRE) -- MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management...
gmi 2018.png
Worldwide Instrument Transformer Market to hit $8 billion by 2025: Global Market Insights, Inc.
12 mars 2019 01h30 HE | Global Market Insights, Inc
Sellbyville, Delaware, March 12, 2019 (GLOBE NEWSWIRE) -- The U.S. instrument transformer market is anticipated to observe growth on account of rising demand for the refurbishment of conventional...
Crawford Supports Si
Crawford Supports Silver Oxysalts™ Speaker Panel at the Symposium for Advanced Wound Care
13 avr. 2017 09h03 HE | Crawford Healthcare
DOYLESTOWN, Pa., April 13, 2017 (GLOBE NEWSWIRE) -- Crawford Healthcare, Inc. (“Crawford” or the “Company”) recently supported a panel of speakers at the Symposium for Advanced Wound Care (SAWC) in...
Kerecis to Participate in the Military Health System Research Symposium, August 18 to 21
14 août 2014 21h28 HE | Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwired - Aug 14, 2014) -  Kerecis Limited, the emerging leader in tissue-regeneration materials, will participate in the Military Health System...
Kerecis to Present at NASDAQ OMX
23 mai 2014 11h19 HE | Kerecis
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwired - May 23, 2014) - Kerecis Limited, the emerging leader in tissue-regeneration materials, will participate in the NASDAQ OMX Iceland Prospect...